FEMY vs WRB · rev $1.6M vs P/E 17, rev $14.71B
Femasys Inc (FEMY) versus W. R. Berkley Corp (WRB) — a side-by-side from cached financials, not a winner call.
Femasys Inc (FEMY) is a medical instruments & supplies company listed on US.
W. R. Berkley Corp (WRB) is a insurance - property & casualty company listed on US.
Latest reported FEMY revenue for 2024-12-31 was $1.6M. Net income was -$18.8M. Revenue was up 52.0% from 2023-12-31 to 2024-12-31. FEMY currently screens at market cap $925.2K.
Latest reported WRB revenue for 2025-12-31 was $14.71B. Net income was $1.78B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. WRB currently screens at market cap $27.12B and trailing P/E 16.6.
FEMY currently screens at market cap $925.2K. WRB currently screens at market cap $27.12B and trailing P/E 16.6.
Not investment advice. Open the FEMY and WRB stock pages for the full models.
Not investment advice.